Role of raltegravir in the management of HIV-1 infection

N Lance Okeke1, Charles Hicks21Duke University Medical Center, Department of Hospital Medicine, Durham Regional Hospital, Durham, North Carolina, USA; 2Duke University School of Medicine, Durham, NC, USAAbstract: The development of multiple agents with potent antiretroviral activity against HIV has...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Okeke NL, Hicks C
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2011
Materias:
Acceso en línea:https://doaj.org/article/5d6e929b0b704a0394db3b00948044ff
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5d6e929b0b704a0394db3b00948044ff
record_format dspace
spelling oai:doaj.org-article:5d6e929b0b704a0394db3b00948044ff2021-12-02T07:07:20ZRole of raltegravir in the management of HIV-1 infection1179-1373https://doaj.org/article/5d6e929b0b704a0394db3b00948044ff2011-07-01T00:00:00Zhttp://www.dovepress.com/role-of-raltegravir-in-the-management-of-hiv-1-infection-a7878https://doaj.org/toc/1179-1373N Lance Okeke1, Charles Hicks21Duke University Medical Center, Department of Hospital Medicine, Durham Regional Hospital, Durham, North Carolina, USA; 2Duke University School of Medicine, Durham, NC, USAAbstract: The development of multiple agents with potent antiretroviral activity against HIV has ushered in a new age of optimism in the management of patients infected with the virus. However, the viruses’ dynamic ability to develop resistance against these agents necessitates the investigation of novel targets for viral suppression. Raltegravir represents a first-in-class agent targeting the HIV integrase enzyme, which is responsible for integration of virally encoded DNA into the host genome. Over the last 5 years, clinical trials data has demonstrated an increasing role for raltegravir in the management of both treatment-experienced and treatment-naïve HIV-1-infected patients. This review focuses on the evidence supporting raltegravir’s efficacy in an array of clinical settings. Other HIV-1 integrase inhibitors in development are also briefly discussed.Keywords: HIV, antiretroviral therapy, raltegravir Okeke NLHicks CDove Medical PressarticleImmunologic diseases. AllergyRC581-607ENHIV/AIDS: Research and Palliative Care, Vol 2011, Iss default, Pp 81-92 (2011)
institution DOAJ
collection DOAJ
language EN
topic Immunologic diseases. Allergy
RC581-607
spellingShingle Immunologic diseases. Allergy
RC581-607
Okeke NL
Hicks C
Role of raltegravir in the management of HIV-1 infection
description N Lance Okeke1, Charles Hicks21Duke University Medical Center, Department of Hospital Medicine, Durham Regional Hospital, Durham, North Carolina, USA; 2Duke University School of Medicine, Durham, NC, USAAbstract: The development of multiple agents with potent antiretroviral activity against HIV has ushered in a new age of optimism in the management of patients infected with the virus. However, the viruses’ dynamic ability to develop resistance against these agents necessitates the investigation of novel targets for viral suppression. Raltegravir represents a first-in-class agent targeting the HIV integrase enzyme, which is responsible for integration of virally encoded DNA into the host genome. Over the last 5 years, clinical trials data has demonstrated an increasing role for raltegravir in the management of both treatment-experienced and treatment-naïve HIV-1-infected patients. This review focuses on the evidence supporting raltegravir’s efficacy in an array of clinical settings. Other HIV-1 integrase inhibitors in development are also briefly discussed.Keywords: HIV, antiretroviral therapy, raltegravir 
format article
author Okeke NL
Hicks C
author_facet Okeke NL
Hicks C
author_sort Okeke NL
title Role of raltegravir in the management of HIV-1 infection
title_short Role of raltegravir in the management of HIV-1 infection
title_full Role of raltegravir in the management of HIV-1 infection
title_fullStr Role of raltegravir in the management of HIV-1 infection
title_full_unstemmed Role of raltegravir in the management of HIV-1 infection
title_sort role of raltegravir in the management of hiv-1 infection
publisher Dove Medical Press
publishDate 2011
url https://doaj.org/article/5d6e929b0b704a0394db3b00948044ff
work_keys_str_mv AT okekenl roleofraltegravirinthemanagementofhiv1infection
AT hicksc roleofraltegravirinthemanagementofhiv1infection
_version_ 1718399571891060736